Istradefylline (KW-6002) is a potent and selective adenosine A2A receptor antagonist (Ki=2.2 nM) in Phase 3 development. Its research applications extend to Parkinsons disease, sleep disorders, and substance abuse, with studies utilizing both in vitro binding assays and in vivo models of neurological function.
Molecular Weight:
384.43
Purity:
99.95% (May vary between batches)
CAS Number:
[155270-99-8]
Formula:
C20H24N4O4
Target:
Adenosine Receptor
Application Notes:
Solubility: DMSO:13.38 mg/mL (34.8 mM)
* VAT and and shipping costs not included. Errors and price changes excepted